| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -3.9e-05 | 1 |